A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
The confused puzzles in antineutrophil cytoplasmic antibody‐associated vasculitis activity evaluation: A case report
2021
Clinical Case Reports
BACKGROUND Disease activity and treatment-related toxicity are the most important contributors to poor prognosis in patients with ANCA-associated vasculitis (AAV). Sometimes, it is difficult to distinguish them. We present a case to highlight the challenges in the management of AAV and the complications with immunosuppression. An 81-year-old female patient presented to our institution with gross hematuria, fatigue, nausea, anorexia, and progressively deteriorating renal function. ANCA enzyme
doi:10.1002/ccr3.4497
fatcat:dho47ru2u5dy7puw3lpcwbgylq